Company profile
Aecor Bio company profile
Aecor.bio is a company focused on developing novel peptide therapies to overcome treatment resistance, a major challenge in many diseases. They use AI-driven methods to design and synthesize peptides targeting disrupted gene expression responsible for treatment resistance at the cellular level. Their approach includes synthesizing thousands of unique peptides with proprietary algorithms, identifying gene expression changes linked to resistance, and repairing cellular micro-environments to reverse these changes.
Business identity
- Website
- https://aecorbio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2023-01-01
Headquarters
- Headquarters
- New Lisbon, Wisconsin, United States
- Country code
- US
- Continent
- North America